Home / News / Meridian Medical Technologies, a Kindeva Drug Delivery company, investing $100+ Million in Bridgeton, Missouri, expansion

Meridian Medical Technologies, a Kindeva Drug Delivery company, investing $100+ Million in Bridgeton, Missouri, expansion

April 11, 2023

St. Louis, Mo. and St. Paul, Minn.; April 11, 2023 (Business Wire) – Meridian Medical Technologies, a Kindeva Drug Delivery Company, a leading global contract development and manufacturing organization (CDMO) focused on drug-device combination products, announced today, during National Community Development Week, it will expand manufacturing capabilities in Bridgeton, Missouri — investing more than $100 million over the next four years in a newly purchased facility. Meridian, which recently combined with Kindeva, will be converting this new 155,000-square-foot facility to support increased production of drug-device combination products, sterile fill-finish capabilities, and create job opportunities in the St. Louis area.

“We’re proud to have a leading, high-tech manufacturer like Meridian Medical Technologies expanding in St. Louis,” said Gov. Mike Parson. “It’s always exciting to see a local employer thriving, creating jobs, and developing innovative products right here in our state. We wish Meridian the best and look forward to its future growth as it continues to succeed in the region.”

Meridian founded the autoinjector technology and has been a leading manufacturer of emergency autoinjectors for more than 60 years. Now with Kindeva, the combined company has a broader range of drug delivery capabilities that this Bridgeton facility investment will help support worldwide.

“Meridian brings a strong history of specific expertise to support critical manufacturing capabilities for complex products — addressing a manufacturing shortage we have seen increase over the last several years,” said Milton Boyer, Meridian CEO. “Building a broader platform with the latest technologies and equipment available, coupled with enhanced capabilities in the production of pre-filled syringes and cartridges, will enable Meridian to offer a broader array of CDMO services and increased capacity to our customers.”

Since January 2022, Meridian has added approximately 300 employees for a total of approximately 900 in the St. Louis area. The company’s new facility, which will be completed in 2024, will support continued growth by dramatically increasing its abilities to develop and manufacture products that will bring new medicines to new markets and customers worldwide.

For this expansion, Meridian will benefit from the Missouri Works program, a tool that helps companies expand and retain workers by providing access to capital through withholdings or tax credits for job creation.

“It’s exciting to see Meridian Medical Technologies create more opportunities for Missourians in St. Louis,” said Maggie Kost, Acting Director of the Department of Economic Development. “As Meridian expands while developing lifesaving products, we’re grateful to support its growth. This company is another example of a quality local employer making a positive difference for our state and beyond.”

What Others Are Saying

“The city of Bridgeton welcomes Meridian Medical Technologies to the city,” said Mayor Terry Briggs. “Not only will Meridian bring well-paying jobs to our city, but the medical products it develops here will help countless people throughout the world. We look forward to working with them.”

“The expansion of Meridian Medical Technologies is a significant step forward for St. Louis,” said County Councilwoman Kelli Dunaway. “Their investment in our community not only brings economic benefits, but also underscores St. Louis’ position as a hub for innovation and advancement in the healthcare industry. It is exciting to see a company like Meridian recognize the potential in our region, and we look forward to the positive impact they will have on our community.”

“The expansion of Meridian Medical Technologies will provide more jobs and increase production in St. Louis County,” said County Executive Dr. Sam Page. “With the help of the St. Louis Economic Development Partnership, we have worked to create a path for growth to a business that employs approximately 900 people in St. Louis County.”

“Meridian’s expansion brings not only new investment and new jobs to the St. Louis metro, but highlights the continued growth of our bioscience and advanced manufacturing sectors,” said Jason Hall, CEO of Greater St. Louis, Inc. “We are excited by Meridian’s expansion and their commitment to St. Louis and appreciate the hard work and collaboration of the economic development partners at the state and regional level who helped make this project happen.”

“The St. Louis region has so much to offer in the biosciences and medical industry. We are excited Meridian Medical Technologies will be expanding its operations here and bringing more jobs to Missouri,” said Tara Oglesby, Vice President of Community, Economic Development and Energy Solutions at Ameren Missouri. “Ameren Missouri’s Smart Energy Plan continues to be instrumental in making the region more attractive for businesses to grow here while also providing reliable energy to power the quality of life for the customers and communities we serve.”

About Kindeva Drug Delivery

Kindeva is a global contract development manufacturing organization focused on drug-device combination products. Kindeva develops and manufactures products across a broad range of complex drug-delivery formats, including autoinjectors, inhalers, transdermal patches, and microneedles. Its service offering spans early-stage feasibility through commercial scale drug product fill-finish, container closure system manufacturing, and drug-device product assembly. Kindeva serves a global client base in the commercial and health security markets from its nine manufacturing and research and development facilities located in the U.S. and U.K. 

About the Missouri Department of Economic Development
The Missouri Department of Economic Development (DED) works to create an environment that encourages economic growth by supporting Missouri’s businesses and diverse industries, strengthening our communities, developing a talented and skilled workforce, and maintaining a high quality of life. As one team built around the customer and driven by data, DED aspires to be the best economic development department in the Midwest. Through its various initiatives, DED is helping create opportunities for Missourians to prosper.

For the latest updates on DED’s current or future programs and initiatives, visit DED’s website.

About the Missouri Works Program
As the state’s number one incentive tool for expansion and retention, the Missouri Works Program helps businesses access capital through withholdings or tax credits to embark on facility expansions and create jobs. This program can also help businesses purchase equipment to maintain its facility in Missouri.

Share article:

Related news

Explore more of our latest news and announcements, where the demands of today meet the possibilities of tomorrow.

Kindeva Drug Delivery completes registration batch at state-of-the-art aseptic injectable fill finish facility

ST. LOUIS; Oct. 8, 2024 (Business Wire) – Kindeva Drug Delivery (Kindeva), a leading global CDMO, today announced two key milestones for its state-of-the-art Bridgeton, MO, facility. The site has successfully completed its first registration batch on its groninger high-volume vial line. This achievement showcases the facility’s readiness to meet the growing demand for injectable […]

Learn More

Kindeva Drug Delivery’s Woodbury analytical services site: Inspected by the FDA

WOODBURY, Minn.; July 16, 2024 (Business Wire) – Global drug-device combination product CDMO Kindeva Drug Delivery today announced that their Woodbury, MN facility has been inspected, successfully classified by the FDA, and continues to support clients through the analytical services global business unit. The new business unit, launched earlier this year, supports both integrated and […]

Learn More

Kindeva Drug Delivery expands Loughborough, UK, facilities at Charnwood campus to support growth of green propellant commercialization

LOUGHBOROUGH, UK, WOODBURY, Minn., and ST. LOUIS, Mo.; June 4, 2024 (Business Wire) – Leading global drug-device combination product CDMO Kindeva Drug Delivery (Kindeva) today announced the expansion of their Loughborough, U.K., facilities at the Charnwood Campus Science Innovation and Technology Park. This strategic move by Kindeva supports the growth of green propellant commercialization and […]

Learn More

Kindeva Drug Delivery invests in second manufacturing line for greener inhalers at UK manufacturing site

WOODBURY, Minn. and ST. LOUIS, Mo.; May 6, 2024 (Business Wire) – Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today announced its investment in a second manufacturing line for the production of pressurized metered-dose inhaler (pMDI) products containing low-GWP (Global Warming Potential) propellants in its Loughborough, U.K., facility. This new line will […]

Learn More

Kindeva Drug Delivery launches new Analytical Services Global Business Unit

WOODBURY, Minn. and ST. LOUIS, Mo.; Jan. 31, 2024 (Business Wire) – Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, announced the expansion of its analytical services capabilities — launching a new global business unit offering integrated and stand-alone analytical support to the wider pharmaceutical, biopharmaceutical, and medical device sector. For more than half […]

Learn More

U.K. Government grant unlocks £33M investment with Kindeva Drug Delivery for greener inhaler future

WOODBURY, Minn. and ST. LOUIS, Mo.; Aug. 3, 2023 (Business Wire) — Kindeva Drug Delivery (Kindeva), a premier global drug delivery device contract development and manufacturing organization (CDMO), announced that the company has received a grant from the U.K. Government’s Life Sciences Innovation Manufacturing Fund (LSIMF), unlocking a £33 million investment with Kindeva toward enhancing […]

Learn More

Kindeva Drug Delivery to manufacture new, greener inhalers at UK manufacturing site to help cut carbon emissions

February 16, 2022 – One of the UK’s biggest asthma inhaler manufacturers has today announced its intention to invest in its UK manufacturing site to support the development of a new generation of greener inhalers, designed to help support the National Health Service (NHS) to cut a contributor to its emissions. The new inhalers will […]

Learn More

Manufacturing more tomorrows

Partner with us and benefit from a team with technical expertise and a passion for purpose. As a true partner, strategically minded and dedicated to your lasting legacy, we provide customized solutions tailored to your precise requirements. From development to commercial manufacturing and beyond, our CDMO solutions are designed to help your product progress with purpose.